Interkingdom glycine conjugates of indole-3-carboxylates are Ah receptor ligands

This study reveals that host and microbial glycine conjugation of indole-3-carboxylates generates bioactive metabolites, such as IAA-Glycine, which function as direct human Ah receptor ligands, thereby establishing a novel interkingdom link between plant-derived auxin chemistry and human physiology.

The Gist

The Big Picture: A Secret Language Between Plants, Bugs, and You

Imagine your body is a bustling city. Inside this city, there is a very important "security guard" and "switchboard operator" called the AHR (Aryl Hydrocarbon Receptor). This guard doesn't just watch for bad guys (toxins); it also listens to a secret language spoken by plants, bacteria, and your own body to decide how to keep the city running smoothly.

For a long time, scientists thought this guard only listened to loud, dangerous noises (like pollution or cigarette smoke). But this paper reveals that the guard is actually very tuned in to a quiet, everyday conversation happening between the food we eat, the bacteria in our gut, and our own cells.

The Main Characters: The "Indole" Messengers

The study focuses on two specific messengers made from an amino acid called Tryptophan (found in turkey, milk, and nuts):

1. IAA (Indole-3-acetic acid): A messenger that helps plants grow.
2. IPA (Indole-3-propionic acid): A powerful antioxidant that protects your brain and gut.

These messengers are made by both the bacteria in your gut and your own body. They travel through your blood to tell the AHR guard to "stand down" (reduce inflammation) or "get to work" (repair tissue).

The Twist: The "Glycine" Backpack

Here is where it gets interesting. The paper discovered that your body (and your gut bugs) often attach a tiny "backpack" to these messengers. This backpack is made of an amino acid called Glycine.

Think of it like this:

• The Messenger (IAA) is a courier delivering a package.
• The Backpack (Glycine) is a small satchel attached to the courier to help them move faster or hide better.

Scientists used to think that if you put a backpack on a messenger, the guard (AHR) wouldn't recognize them anymore. They thought the backpack would block the message.

The Surprise:

• For IPA (The Brain Protector): Putting the Glycine backpack on it actually silenced the message. The guard couldn't hear it anymore.
• For IAA (The Plant Growth Signal): Putting the Glycine backpack on it did not silence the message. The guard still heard the courier clearly! In fact, the "backpacked" version (IAA-Glycine) is still a very strong signal for humans.

The Species Swap: Humans vs. Mice

This is a crucial finding. The researchers tested this on both mice and humans.

• Mice: The AHR guard in mice is very picky. It reacts strongly to pollution but is a bit deaf to these natural "backpacked" messengers.
• Humans: Our AHR guard is different. It is much more sensitive to these natural messengers (IAA and its backpacked version) than the mouse guard is.

The Analogy: Imagine a radio station. The mouse radio is tuned to a loud, static-filled frequency (pollution). The human radio is tuned to a clear, high-definition frequency (natural food/bacteria signals). This study shows that our bodies rely heavily on these natural signals to stay healthy, perhaps more than we realized.

Why Does This Matter?

1. It's a Universal Language: Plants make IAA to grow. Bacteria make IAA to talk to each other. Humans make IAA to talk to our own immune system. This paper shows that we are all speaking the same chemical language, and our bodies are listening.
2. The "Backpack" is a Delivery System: The study suggests that attaching the Glycine backpack helps the body get rid of these messengers through urine. It's like a recycling truck picking up the package after it's delivered. But interestingly, the package still works before it gets thrown away.
3. Health Implications: Because IAA and its backpacked version are still active, they might be helping us fight inflammation and repair our gut lining every day. If we eat a diet rich in tryptophan (like turkey or nuts) and have a healthy gut, we are constantly sending these "repair crews" to our AHR guard.

The Takeaway

Your body isn't just a passive machine; it's a complex ecosystem where plants, bacteria, and your own cells are constantly chatting. This study found that even when your body puts a "backpack" on these chat messages to clean them up, the message still gets through loud and clear to your human immune system.

It turns out that the "junk" we thought was just waste (the glycine-conjugated messengers) is actually a vital part of how our bodies stay healthy, fight disease, and maintain the delicate balance between us and the microscopic world inside us.

Technical Summary

1. Problem Statement

The Aryl Hydrocarbon Receptor (AHR) is a critical transcription factor regulating barrier tissue homeostasis, immunity, and detoxification. While its role as a sensor for environmental xenobiotics (e.g., TCDD) is well-established, the mechanisms governing its activation by endogenous ligands—specifically tryptophan metabolites derived from host and microbiota metabolism—remain poorly understood.

• Knowledge Gap: It is unclear how the host and microbiome metabolize and clear abundant tryptophan metabolites like Indole-3-acetic acid (IAA) and Indole-3-propionic acid (IPA).
• Specific Question: Do Phase II metabolic modifications, specifically glycine conjugation, alter the bioactivity of these metabolites? Conventional dogma suggests that conjugation (e.g., glycination) typically inactivates ligands or prepares them solely for excretion. This study investigates whether glycine-conjugated indoles retain AHR agonist activity and how this varies between species (mouse vs. human).

2. Methodology

The study employed a multi-disciplinary approach combining metabolomics, cell biology, structural biology, and in vivo animal models.

• Metabolomics & Quantification:
  • Samples: Serum, urine, feces, cecal contents, liver, and kidney tissues from germ-free (GF) and conventional mice (fed chow or phytochemical-free AIN-93G diets), as well as human serum and fecal samples from a controlled diet cohort ($n=40$).
  • Technique: High-resolution LC-MS (ZenoTOF 7600) with stable isotope-labeled internal standards to quantify IAA, IPA, and their glycine conjugates (IAA-Gly, IPA-Gly).
• Cell-Based Functional Assays:
  • Reporter Assays: Luciferase assays in mouse Hepa1.1 and human HepG2(40/6) cells to measure AHR-dependent transcriptional activity.
  • Gene Expression: qPCR analysis of Cyp1a1 (mouse) and CYP1A1 (human) induction.
  • Inflammatory Model: Primary human synovial fibroblasts treated with IAA/IAA-Gly and IL-1$\beta$ to assess synergistic induction of SERPINB2 (PAI-2), an AHR-regulated inflammatory marker.
  • Uptake & Stability: Cellular uptake assays and incubation studies to determine if conjugates are deconjugated intracellularly to release the parent ligand.
• Structural Biology (Computational):
  • Molecular Docking: AutoDock Vina was used to dock IAA, IAA-Gly, and IAA-Ser into the PAS-B domain of the human AHR (based on Cryo-EM structure PDB: 7ZUB).
  • Analysis: Comparison of binding poses, planarity, and hydrophobic interactions relative to the high-affinity ligand indirubin.
• Biochemical Assays:
  • Antioxidant Capacity: ORAC assay to measure the intrinsic chemical antioxidant potential of the metabolites.
  • In Vitro Conjugation: Incubation of hepatic and renal mitochondrial lysates with IAA and glycine to identify the site of conjugation.

3. Key Contributions & Results

A. Metabolic Fate and Species Differences

• Glycine Conjugation: Both IAA and IPA undergo glycine conjugation in mice. However, IAA-Gly is abundant in human serum (mean ~1.4 $\mu$M), whereas IPA-Gly is undetectable in human serum.
• Microbial vs. Host Origin:
  • IPA: Strictly microbial (absent in GF mice).
  • IAA: Produced by both host and microbiota.
  • Conjugation Site: In mice, glycine conjugation of IAA occurs primarily in the kidney (renal lysates showed higher conjugation activity than liver), facilitating urinary excretion. In humans, the presence of IAA-Gly in serum suggests reabsorption or systemic circulation.
• Dietary Influence: A phytochemical-free diet significantly reduced serum and cecal levels of IPA and IPA-Gly in mice, confirming dietary/microbial dependence for IPA.

B. AHR Activation Potential (The Core Discovery)

• IAA-Gly is an Active Ligand: Contrary to the assumption that conjugation inactivates ligands, IAA-Gly retains significant AHR agonist activity.
  • Human AHR: IAA-Gly activates human AHR (inducing CYP1A1) with ~4-fold lower potency than unconjugated IAA, but remains a potent agonist at physiological concentrations (effective >3 $\mu$M).
  • Mouse AHR: IAA-Gly activates mouse AHR but requires higher concentrations (>6 $\mu$M) than found in mouse serum, suggesting it is less physiologically relevant in mice than in humans.
• Structural Specificity: The activity is highly specific to the glycine moiety. Conjugation with other amino acids (Alanine, Glutamine, Serine, Threonine) generally abolished or drastically reduced AHR activation, except for IAA-Ala in human cells (which showed weak activity).
• Mechanism: The activation is not due to intracellular deconjugation back to IAA; cells incubated with IAA-Gly did not generate detectable IAA, confirming IAA-Gly acts directly.

C. Structural Insights (Docking Studies)

• Planarity is Key: Computational docking revealed that IAA and IAA-Gly adopt a planar conformation within the AHR ligand-binding pocket that closely mimics the high-affinity ligand indirubin. They engage key hydrophobic residues (F295, I325, C333).
• Loss of Activity in Other Conjugates: IAA-Ser, despite having high binding affinity in silico, adopts a kinked (non-planar) conformation at high affinity, failing to align with the prototypical binding mode required for receptor activation. This explains why IAA-Ser is inactive despite binding.

D. Species-Specific Sensitivity

• Human vs. Mouse: While xenobiotics (TCDD, FICZ) activate mouse AHR more potently than human AHR, endogenous tryptophan metabolites (IAA, IAA-Gly) activate human AHR more potently (1.2–1.9 fold) than mouse AHR. This suggests human AHR signaling is uniquely tuned to these host-microbial metabolites.

E. Functional Synergy

• Inflammation: IAA-Gly synergizes with the inflammatory cytokine IL-1$\beta$ to induce SERPINB2 (PAI-2) in human synoviocytes. This effect is AHR-dependent (blocked by GNF351).
• Antioxidant Activity: While individual metabolites showed variable antioxidant capacity, combinations of IAA, IAA-Gly, and IPA exhibited significant synergistic antioxidant potential, suggesting a collective protective role against oxidative stress.

4. Significance

• Redefining the AHR "Exposome": The study identifies IAA-Gly as a previously unrecognized, bioactive endogenous AHR ligand. This expands the known repertoire of AHR ligands beyond unconjugated metabolites.
• Interkingdom Communication: The findings highlight a shared chemical language between plants (where IAA is a major auxin), microbes, and humans. Glycine conjugation, a mechanism used by plants for storage and transport, is repurposed in mammals for clearance but retains signaling capability.
• Physiological Relevance: The discovery that human AHR is more sensitive to these tryptophan metabolites than mouse AHR challenges the reliance on mouse models for studying AHR-mediated physiology in humans. It suggests that basal AHR activity in humans is significantly driven by the "IAA/IAA-Gly axis."
• Therapeutic Implications: Understanding that conjugated metabolites remain active opens new avenues for targeting AHR in inflammatory diseases (e.g., rheumatoid arthritis, metabolic syndrome) and suggests that dietary or microbial modulation of glycine conjugation could be a therapeutic strategy.

In summary, this paper demonstrates that glycine conjugation does not necessarily silence AHR ligands; rather, it creates a distinct class of bioactive metabolites (specifically IAA-Gly) that are abundant in human serum and function as potent, species-specific regulators of AHR-dependent physiology.